MovDisordV3, PascalFrancis, Corpus, bibRecord, 002D94

Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

Identifieur interne : 002D94 ( PascalFrancis/Corpus ); précédent : 002D93; suivant : 002D95

Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

Auteurs : H. H. Fernandez ; J. H. Friedman ; C. Jacques ; M. Rosenfeld

Source :

Movement disorders [ 0885-3185 ] ; 1999.

RBID : Pascal:99-0271871

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Antiparkinsonien, Psychose, Quétiapine, Chimiothérapie, Neuroleptique, Psychotrope, Antipsychotique, Traitement, Toxicité, Personne âgée, Changement médicament.

English descriptors

KwdEn :
- Antiparkinson agent, Antipsychotic, Chemotherapy, Drug switching, Elderly, Neuroleptic, Parkinson disease, Psychosis, Psychotropic, Quetiapine, Toxicity, Treatment.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 14`
A06				`@2 3`
A08	`01`	`1`	`ENG`	`@1 Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease`
A11	`01`	`1`		`@1 FERNANDEZ (H. H.)`
A11	`02`	`1`		`@1 FRIEDMAN (J. H.)`
A11	`03`	`1`		`@1 JACQUES (C.)`
A11	`04`	`1`		`@1 ROSENFELD (M.)`
A14	`01`			`@1 Movement Disorders Unit, Department of Neurology, Brown University School of Medicine, Memorial Hospital of Rhode Island @2 Pawtucket, Rhode Island @3 USA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut.`
A20				`@1 484-487`
A21				`@1 1999`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000084162660150`
A44				`@0 0000 @1 © 1999 INIST-CNRS. All rights reserved.`
A45				`@0 21 ref.`
A47	`01`	`1`		`@0 99-0271871`
A60				`@1 P @3 CC`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C02	`01`	`X`		`@0 002B02B10`
C02	`02`	`X`		`@0 002B02U01`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Antiparkinsonien @5 02`
C03	`02`	`X`	`ENG`	`@0 Antiparkinson agent @5 02`
C03	`02`	`X`	`SPA`	`@0 Antiparkinsoniano @5 02`
C03	`03`	`X`	`FRE`	`@0 Psychose @5 04`
C03	`03`	`X`	`ENG`	`@0 Psychosis @5 04`
C03	`03`	`X`	`SPA`	`@0 Psicosis @5 04`
C03	`04`	`X`	`FRE`	`@0 Quétiapine @2 NK @2 FR @5 07`
C03	`04`	`X`	`ENG`	`@0 Quetiapine @2 NK @2 FR @5 07`
C03	`04`	`X`	`SPA`	`@0 Quetiapina @2 NK @2 FR @5 07`
C03	`05`	`X`	`FRE`	`@0 Chimiothérapie @5 08`
C03	`05`	`X`	`ENG`	`@0 Chemotherapy @5 08`
C03	`05`	`X`	`SPA`	`@0 Quimioterapia @5 08`
C03	`06`	`X`	`FRE`	`@0 Neuroleptique @5 09`
C03	`06`	`X`	`ENG`	`@0 Neuroleptic @5 09`
C03	`06`	`X`	`SPA`	`@0 Neuroléptico @5 09`
C03	`07`	`X`	`FRE`	`@0 Psychotrope @2 FX @5 10`
C03	`07`	`X`	`ENG`	`@0 Psychotropic @2 FX @5 10`
C03	`07`	`X`	`SPA`	`@0 Psicotropo @2 FX @5 10`
C03	`08`	`X`	`FRE`	`@0 Antipsychotique @5 11`
C03	`08`	`X`	`ENG`	`@0 Antipsychotic @5 11`
C03	`08`	`X`	`SPA`	`@0 Antipsicótico @5 11`
C03	`09`	`X`	`FRE`	`@0 Traitement @5 17`
C03	`09`	`X`	`ENG`	`@0 Treatment @5 17`
C03	`09`	`X`	`SPA`	`@0 Tratamiento @5 17`
C03	`10`	`X`	`FRE`	`@0 Toxicité @5 18`
C03	`10`	`X`	`ENG`	`@0 Toxicity @5 18`
C03	`10`	`X`	`SPA`	`@0 Toxicidad @5 18`
C03	`11`	`X`	`FRE`	`@0 Personne âgée @5 20`
C03	`11`	`X`	`ENG`	`@0 Elderly @5 20`
C03	`11`	`X`	`SPA`	`@0 Anciano @5 20`
C03	`12`	`X`	`FRE`	`@0 Changement médicament @4 CD @5 96`
C03	`12`	`X`	`ENG`	`@0 Drug switching @4 CD @5 96`
C07	`01`	`X`	`FRE`	`@0 Homme`
C07	`01`	`X`	`ENG`	`@0 Human`
C07	`01`	`X`	`SPA`	`@0 Hombre`
C07	`02`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`02`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`02`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`03`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`03`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`03`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`04`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`04`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`04`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`05`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`05`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`05`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`06`	`X`	`FRE`	`@0 Maladie dégénérative @5 41`
C07	`06`	`X`	`ENG`	`@0 Degenerative disease @5 41`
C07	`06`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 41`
N21				`@1 165`

Format Inist (serveur)

NO :	PASCAL 99-0271871 INIST
ET :	Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
AU :	FERNANDEZ (H. H.); FRIEDMAN (J. H.); JACQUES (C.); ROSENFELD (M.)
AF :	Movement Disorders Unit, Department of Neurology, Brown University School of Medicine, Memorial Hospital of Rhode Island/Pawtucket, Rhode Island/Etats-Unis (1 aut., 2 aut., 3 aut., 4 aut.)
DT :	Publication en série; Courte communication, note brève; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1999; Vol. 14; No. 3; Pp. 484-487; Bibl. 21 ref.
LA :	Anglais
CC :	002B02B10; 002B02U01
FD :	Parkinson maladie; Antiparkinsonien; Psychose; Quétiapine; Chimiothérapie; Neuroleptique; Psychotrope; Antipsychotique; Traitement; Toxicité; Personne âgée; Changement médicament
FG :	Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative
ED :	Parkinson disease; Antiparkinson agent; Psychosis; Quetiapine; Chemotherapy; Neuroleptic; Psychotropic; Antipsychotic; Treatment; Toxicity; Elderly; Drug switching
EG :	Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease
SD :	Parkinson enfermedad; Antiparkinsoniano; Psicosis; Quetiapina; Quimioterapia; Neuroléptico; Psicotropo; Antipsicótico; Tratamiento; Toxicidad; Anciano
LO :	INIST-20953.354000084162660150
ID :	99-0271871

Links to Exploration step

Pascal:99-0271871

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease</title>
<author><name sortKey="Fernandez, H H" sort="Fernandez, H H" uniqKey="Fernandez H" first="H. H." last="Fernandez">H. H. Fernandez</name>
<affiliation><inist:fA14 i1="01"><s1>Movement Disorders Unit, Department of Neurology, Brown University School of Medicine, Memorial Hospital of Rhode Island</s1>
<s2>Pawtucket, Rhode Island</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Friedman, J H" sort="Friedman, J H" uniqKey="Friedman J" first="J. H." last="Friedman">J. H. Friedman</name>
<affiliation><inist:fA14 i1="01"><s1>Movement Disorders Unit, Department of Neurology, Brown University School of Medicine, Memorial Hospital of Rhode Island</s1>
<s2>Pawtucket, Rhode Island</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Jacques, C" sort="Jacques, C" uniqKey="Jacques C" first="C." last="Jacques">C. Jacques</name>
<affiliation><inist:fA14 i1="01"><s1>Movement Disorders Unit, Department of Neurology, Brown University School of Medicine, Memorial Hospital of Rhode Island</s1>
<s2>Pawtucket, Rhode Island</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rosenfeld, M" sort="Rosenfeld, M" uniqKey="Rosenfeld M" first="M." last="Rosenfeld">M. Rosenfeld</name>
<affiliation><inist:fA14 i1="01"><s1>Movement Disorders Unit, Department of Neurology, Brown University School of Medicine, Memorial Hospital of Rhode Island</s1>
<s2>Pawtucket, Rhode Island</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">99-0271871</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 99-0271871 INIST</idno>
<idno type="RBID">Pascal:99-0271871</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002D94</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease</title>
<author><name sortKey="Fernandez, H H" sort="Fernandez, H H" uniqKey="Fernandez H" first="H. H." last="Fernandez">H. H. Fernandez</name>
<affiliation><inist:fA14 i1="01"><s1>Movement Disorders Unit, Department of Neurology, Brown University School of Medicine, Memorial Hospital of Rhode Island</s1>
<s2>Pawtucket, Rhode Island</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Friedman, J H" sort="Friedman, J H" uniqKey="Friedman J" first="J. H." last="Friedman">J. H. Friedman</name>
<affiliation><inist:fA14 i1="01"><s1>Movement Disorders Unit, Department of Neurology, Brown University School of Medicine, Memorial Hospital of Rhode Island</s1>
<s2>Pawtucket, Rhode Island</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Jacques, C" sort="Jacques, C" uniqKey="Jacques C" first="C." last="Jacques">C. Jacques</name>
<affiliation><inist:fA14 i1="01"><s1>Movement Disorders Unit, Department of Neurology, Brown University School of Medicine, Memorial Hospital of Rhode Island</s1>
<s2>Pawtucket, Rhode Island</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rosenfeld, M" sort="Rosenfeld, M" uniqKey="Rosenfeld M" first="M." last="Rosenfeld">M. Rosenfeld</name>
<affiliation><inist:fA14 i1="01"><s1>Movement Disorders Unit, Department of Neurology, Brown University School of Medicine, Memorial Hospital of Rhode Island</s1>
<s2>Pawtucket, Rhode Island</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson agent</term>
<term>Antipsychotic</term>
<term>Chemotherapy</term>
<term>Drug switching</term>
<term>Elderly</term>
<term>Neuroleptic</term>
<term>Parkinson disease</term>
<term>Psychosis</term>
<term>Psychotropic</term>
<term>Quetiapine</term>
<term>Toxicity</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Antiparkinsonien</term>
<term>Psychose</term>
<term>Quétiapine</term>
<term>Chimiothérapie</term>
<term>Neuroleptique</term>
<term>Psychotrope</term>
<term>Antipsychotique</term>
<term>Traitement</term>
<term>Toxicité</term>
<term>Personne âgée</term>
<term>Changement médicament</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>14</s2>
</fA05>
<fA06><s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>FERNANDEZ (H. H.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>FRIEDMAN (J. H.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>JACQUES (C.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>ROSENFELD (M.)</s1>
</fA11>
<fA14 i1="01"><s1>Movement Disorders Unit, Department of Neurology, Brown University School of Medicine, Memorial Hospital of Rhode Island</s1>
<s2>Pawtucket, Rhode Island</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>484-487</s1>
</fA20>
<fA21><s1>1999</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000084162660150</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1999 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>21 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>99-0271871</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02B10</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B02U01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Antiparkinsonien</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Antiparkinson agent</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Antiparkinsoniano</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Psychose</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Psychosis</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Psicosis</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Quétiapine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Quetiapine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Quetiapina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Neuroleptique</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Neuroleptic</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Neuroléptico</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Psychotrope</s0>
<s2>FX</s2>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Psychotropic</s0>
<s2>FX</s2>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Psicotropo</s0>
<s2>FX</s2>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Antipsychotique</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Antipsychotic</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Antipsicótico</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Traitement</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Treatment</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Toxicité</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Toxicity</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Toxicidad</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Personne âgée</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Elderly</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Anciano</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Changement médicament</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Drug switching</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fN21><s1>165</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 99-0271871 INIST</NO>
<ET>Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease</ET>
<AU>FERNANDEZ (H. H.); FRIEDMAN (J. H.); JACQUES (C.); ROSENFELD (M.)</AU>
<AF>Movement Disorders Unit, Department of Neurology, Brown University School of Medicine, Memorial Hospital of Rhode Island/Pawtucket, Rhode Island/Etats-Unis (1 aut., 2 aut., 3 aut., 4 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1999; Vol. 14; No. 3; Pp. 484-487; Bibl. 21 ref.</SO>
<LA>Anglais</LA>
<CC>002B02B10; 002B02U01</CC>
<FD>Parkinson maladie; Antiparkinsonien; Psychose; Quétiapine; Chimiothérapie; Neuroleptique; Psychotrope; Antipsychotique; Traitement; Toxicité; Personne âgée; Changement médicament</FD>
<FG>Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative</FG>
<ED>Parkinson disease; Antiparkinson agent; Psychosis; Quetiapine; Chemotherapy; Neuroleptic; Psychotropic; Antipsychotic; Treatment; Toxicity; Elderly; Drug switching</ED>
<EG>Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease</EG>
<SD>Parkinson enfermedad; Antiparkinsoniano; Psicosis; Quetiapina; Quimioterapia; Neuroléptico; Psicotropo; Antipsicótico; Tratamiento; Toxicidad; Anciano</SD>
<LO>INIST-20953.354000084162660150</LO>
<ID>99-0271871</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D94 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002D94 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:99-0271871
   |texte=   Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

Source :

Descripteurs français

English descriptors

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri